Predictive Oncology Stock (NASDAQ: POAI) stock price, news, charts, stock research, profile.
|Vol / Avg.12.182K / 19.689K||Mkt Cap12.352M|
|Day Range3.090 - 3.300||52 Wk Range2.470 - 13.880|
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|2021-06-30||HC Wainwright & Co.||Vernon Bernardino||Initiates Coverage On||Buy||Announces||-||5.00|
|Ticker||Company||Chg %||Mkt Cap|
|NDRA||ENDRA Life Sciences||-2.26%||8.2M|
You can purchase shares of Predictive Oncology (NASDAQ: POAI) through any online brokerage.
The latest price target for Predictive Oncology (NASDAQ: POAI) was reported by HC Wainwright & Co. on Wednesday, June 30, 2021. The analyst firm set a price target for 5.00 expecting POAI to rise to within 12 months (a possible 64.47% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Predictive Oncology (NASDAQ: POAI) is $3.04 last updated Today at December 1, 2023 at 9:35 PM UTC.
There is no dividend information for Predictive Oncology.
Predictive Oncology’s Q3 earnings are confirmed for Monday, November 13, 2023.
There is no upcoming split for Predictive Oncology.
Predictive Oncology is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.